ArticleFrontiers in cardiovascular medicine2024

A budget impact model and a cost-utility analysis of reducer device (Neovasc) in patients with refractory angina.

Agostino Fortunato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.